| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.31 | 1 | 0 |
Innate Inflammatory Response
[description not available] | 0 | 2.31 | 1 | 0 |
Abdominal Migraine
[description not available] | 0 | 22.09 | 173 | 101 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.31 | 1 | 0 |
Migraine Disorders
A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) | 1 | 24.09 | 173 | 101 |
Atypical Cluster Headache
[description not available] | 0 | 2.41 | 1 | 0 |
Ache
[description not available] | 0 | 13.43 | 31 | 29 |
Pain
An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS. | 0 | 13.43 | 31 | 29 |
Cardiovascular Diseases
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. | 0 | 10.36 | 8 | 6 |
Sleepiness
Compelling urge to sleep. | 0 | 3.99 | 1 | 1 |
Dizzyness
[description not available] | 0 | 16.34 | 36 | 10 |
Dizziness
An imprecise term which may refer to a sense of spatial disorientation, motion of the environment, or lightheadedness. | 0 | 16.34 | 36 | 10 |
Nausea
An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses. | 0 | 15.48 | 32 | 5 |
Acute Onset Aura Migraine
[description not available] | 0 | 3.8 | 1 | 1 |
Bilateral Headache
[description not available] | 0 | 11.58 | 18 | 14 |
Headache
The symptom of PAIN in the cranial region. It may be an isolated benign occurrence or manifestation of a wide variety of HEADACHE DISORDERS. | 0 | 11.58 | 18 | 14 |
Migraine with Aura
A subtype of migraine disorder, characterized by recurrent attacks of reversible neurological symptoms (aura) that precede or accompany the headache. Aura may include a combination of sensory disturbances, such as blurred VISION; HALLUCINATIONS; VERTIGO; NUMBNESS; and difficulty in concentrating and speaking. Aura is usually followed by features of the COMMON MIGRAINE, such as PHOTOPHOBIA; PHONOPHOBIA; and NAUSEA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) | 0 | 3.8 | 1 | 1 |
Apoplexy
[description not available] | 0 | 2.41 | 1 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 4.68 | 5 | 0 |
Absence Seizure
[description not available] | 0 | 2.41 | 1 | 0 |
Seizures
Clinical or subclinical disturbances of cortical function due to a sudden, abnormal, excessive, and disorganized discharge of brain cells. Clinical manifestations include abnormal motor, sensory and psychic phenomena. Recurrent seizures are usually referred to as EPILEPSY or seizure disorder. | 0 | 2.41 | 1 | 0 |
Stroke
A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810) | 0 | 2.41 | 1 | 0 |
Kidney Failure
A severe irreversible decline in the ability of kidneys to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. | 0 | 3.52 | 1 | 0 |
Liver Dysfunction
[description not available] | 0 | 3.52 | 1 | 0 |
Liver Diseases
Pathological processes of the LIVER. | 0 | 3.52 | 1 | 0 |
Renal Insufficiency
Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE. | 0 | 3.52 | 1 | 0 |
Serotonin Syndrome
An adverse drug interaction characterized by altered mental status, autonomic dysfunction, and neuromuscular abnormalities. It is most frequently caused by use of both serotonin reuptake inhibitors and monoamine oxidase inhibitors, leading to excess serotonin availability in the CNS at the serotonin 1A receptor. | 0 | 2.6 | 1 | 0 |
Adverse Drug Event
[description not available] | 0 | 8.93 | 7 | 4 |
Drug-Related Side Effects and Adverse Reactions
Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals. | 0 | 8.93 | 7 | 4 |
Acute Kidney Failure
[description not available] | 0 | 2.72 | 2 | 0 |
Injury, Ischemia-Reperfusion
[description not available] | 0 | 2.6 | 1 | 0 |
Reperfusion Injury
Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. | 0 | 2.6 | 1 | 0 |
Acute Kidney Injury
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions. | 0 | 2.72 | 2 | 0 |
Recrudescence
[description not available] | 0 | 7.63 | 4 | 4 |
Muscle Contraction
A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. | 0 | 2.21 | 1 | 0 |
Chemical Dependence
[description not available] | 0 | 4.55 | 1 | 1 |
Substance-Related Disorders
Disorders related to substance use or abuse. | 1 | 6.55 | 1 | 1 |
Acute Disease
Disease having a short and relatively severe course. | 0 | 9.42 | 7 | 5 |
Central Nervous System Origin Vertigo
[description not available] | 0 | 12.16 | 14 | 12 |
Vertigo
An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1) | 0 | 12.16 | 14 | 12 |
Analgesic Overuse Headache
[description not available] | 0 | 2.25 | 1 | 0 |
Allodynia
[description not available] | 0 | 2.25 | 1 | 0 |
Common Migraine
[description not available] | 0 | 7.68 | 4 | 4 |
Migraine without Aura
Recurrent unilateral pulsatile headaches, not preceded or accompanied by an aura, in attacks lasting 4-72 hours. It is characterized by PAIN of moderate to severe intensity; aggravated by physical activity; and associated with NAUSEA and / or PHOTOPHOBIA and PHONOPHOBIA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1) | 0 | 7.68 | 4 | 4 |
Aura
[description not available] | 0 | 3.17 | 1 | 0 |
Epilepsy
A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) | 0 | 3.17 | 1 | 0 |
Lassitude
[description not available] | 0 | 8.69 | 5 | 4 |
Fatigue
The state of weariness following a period of exertion, mental or physical, characterized by a decreased capacity for work and reduced efficiency to respond to stimuli. | 0 | 8.69 | 5 | 4 |
Dysesthesia
[description not available] | 0 | 2.99 | 1 | 0 |